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Abstract: Nitric oxide (NO) is released by endothelial
cells that line the inner walls of healthy blood vessels at
fluxes ranging from 0.5  1010 to 4.0  1010 mol cm2
min1, and this continuous NO release contributes to the
extraordinary thromboresistance of the intact endothelium.
To improve the biocompatibility of blood-contacting devi-
ces, a biomimetic approach to release/generate NO at
polymer/blood interfaces has been pursued recently (with
NO donors or NO generating catalysts doped within poly-
meric coatings) and this concept has been shown to be
effective in preventing platelet adhesion/activation via
several in vivo animal studies. However, there are no
reports to date describing any quantitative in vitro assay to
evaluate the blood compatibilities of such NO release/gen-
erating polymers with controlled NO fluxes. Such a meth-
odology is desired to provide a preliminary assessment of
any new NO-releasing material, in terms of the effective-
ness of given NO fluxes and NO donor amounts on plate-
let activity before the more complex and costly in vivo test-
ing is carried out. In this article, we report the use of a lac-
tate dehydrogenase assay to study in vitro platelet
adhesion on such NO-releasing polymer surfaces with
varying NO fluxes. Reduced platelet adhesion was found
to correlate with increasing NO fluxes. The highest NO
flux tested, 7.05 (60.25)  1010 mol cm2 min1, effec-
tively reduced platelet adhesion to nearly 20% of its origi-
nal level (from 14.0 (62.1)  105 cells cm2 to 2.96 (60.18)
 105 cells cm2) compared to the control polymer coating
without NO release capability.  2007 Wiley Periodicals,
Inc. J Biomed Mater Res 81A: 956–963, 2007
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INTRODUCTION
Nitric oxide (NO) is now widely recognized as a
potent inhibitor of platelet adhesion and activation,1,2
as well as a naturally occurring vasodilator.3 In fact,
the extraordinarily thromboresistant nature of blood
vessel inner walls is, in part, due to the continuous
production of NO by the endothelial cells that line
such vessels.4,5 The NO flux from the endothelium is
estimated to be in the range of 0.5  1010 to 4.0 
1010 mol cm2 min1.4 Previous studies based on the
addition of discrete NO donors into blood samples
suggested that higher NO levels produced from such
donors exert greater antiplatelet activities.6–8 However,
these experiments failed to simulate the function of a
healthy endothelium, which produces a low but con-
tinuous flux of NO from its surface. One report by
Ramamurthi and Lewis using flowing platelets in a
membrane-based diffusion device showed that platelet
adhesion to a collagen-coated membrane (using radio-
labeled platelets) was inhibited by very low fluxes of
NO (much less than physiological fluxes) but the
effect leveled off rapidly as increasing NO fluxes were
used by changing gas phase NO levels on the oppo-
site side of the membrane device.9 Research in this
lab10–20 and elsewhere21,22 has been aimed at preparing
more biocompatible polymeric coatings that continu-
ously produce NO at physiological levels to mimic the
function of the healthy endothelium, thus creating non-
thrombogenic surfaces. Indeed, a growing number of
reports have already demonstrated the improved blood
compatibility of NO-releasing polymeric materials
using in vivo animal model studies.10–15 It has also been
reported that discrete additions of NO or its donor spe-
cies (e.g., diazeniumdiolates, nitrosothiols, etc.) can in-
hibit platelet adhesion and activation in vitro.6–8,23–25
However, there is lack of a simple and reliable in
vitro method to assay the platelet adhesion on poly-
mers that continuously release NO, and to assess
how varying levels of NO release effect platelet ad-
hesion. Such a method would be attractive to carry
out preliminary biocompatibility studies of any new
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NO release/generating polymers, before undertaking
more expensive in vivo testing.
The two most commonly used in vitro platelet ad-
hesion assays are scanning electron microscopy
(SEM)26 and radioisotope-labeled platelet counting.27
However, both methods have their own drawbacks
that render them unsuitable for quantitative assay.
SEM only studies a very small fraction of the total
surface that had been in contact with platelets, of
which the ‘‘representativeness’’ is always question-
able. Radiolabeling, on the other hand, suffers from
the potential for preactivation of platelet as a result
of the labeling step.
In recent years, the assay of lactate dehydrogenase
(LDH) present in platelets has been reported to pro-
vide a useful approach to study in vitro platelet ad-
hesion on chemically and/or physically modified
surfaces.28–32 LDH is normally stored within intact
platelets and other blood cells. Elevated serum LDH
levels are usually associated with cytolytic events.33
When platelets adhered to polymer surfaces are
lysed using a surfactant solution, the amount of
LDH released into the bulk solution is proportional
to the number of cells adhered. The activity of LDH
can be measured by a simple colorimetric assay and
used to quantify platelet adhesion. In this article, we
report, for the first time, the use of an LDH assay to
study the efficacy of varying levels of NO, a bioac-
tive species, released from poly(vinyl chloride)
(PVC) films doped with a lipophilic diazeniumdio-
late type NO donor, in reducing platelet adhesion
onto the surface of such polymeric materials. It will
be shown that increasing fluxes of NO decrease the
observed platelet adhesion.
MATERIALS AND METHODS
Preparation of NO-releasing polymer coatings
Poly(vinyl chloride) (PVC) (average MW ¼ 106,000,
Aldrich, Milwaukee, WI) was mixed with sebacic acid di(2-
ethylhexyl) ester (DOS, Sigma, St. Louis, MO) in dry tetrahy-
drofuran (Fisher, Pittsburgh, PA) to make a solution contain-
ing 2% (w/v) PVC and 2% (w/v) DOS. For control films,
N,N0-dibutyl-1,6-hexanediamine (DBHD, Aldrich) was mixed
with potassium tetrakis(4-chlorophenyl)-borate (KTpClPB,
Fluka, Buchs, Switzerland) in a 1:1 molar ratio and dis-
persed in the polymer solution to yield 4 wt % of DBHD in
the final cured polymer film. The NO adduct, DBHD/N2O2
(diazeniumdiolated DBHD), was synthesized as previously
reported.10 DBHD/N2O2 and equal molar KTpClPB were
dispersed into the polymer casting solution in a similar
manner as the control film to yield 0.50, 1.0, 2.0, and 4.0 wt %
of final DBHD/N2O2 loadings. The coating cocktails were
sonicated for 15 min and then 0.25 mL aliquots were
placed in wells of a 96-well round-bottom polypropylene
microtiterplates (Evergreen Scientific, Los Angeles, CA).
The polymer films were allowed to cure under ambient
condition overnight before 3 mm layers of plain PVC/DOS
(1:1) were applied as top coats. The resulting polymer
films were allowed to cure for another 24 h before use.
NO-release measurement
NO released from the different polymer-coated wells
was measured via a chemiluminescence NO AnalyzerTM,
Model 280 (Sievers Instruments, Boulder, CO), to assess
the NO-release profile and to determine the optimal time
window for platelet adhesion studies. The entire polymer-
coated well was immersed in phosphate buffered saline
(PBS, 137 mM NaCl, 2.7 mM KCl, 10 mM sodium phos-
phate, pH 7.4) at 378C and the solution was bubbled with
N2. NO released from the polymer coating within the well
was purged from the buffer, carried by the N2 gas into the
chemiluminescence reaction chamber of the instrument,
and monitored in real-time.
Platelet adhesion studies
Arterial blood from New Zealand white rabbits, weigh-
ing 2.5–3 kg, was drawn into 9:1 volume of blood:antico-
agulant citrate/phosphate/dextrose solution (Abbott Labs,
North Chicago, IL) containing 15.6 mM citric acid,
89.5 mM tribasic sodium citrate, 16.1 mM NaH2PO4, and
128 mM dextrose. NIH guidelines for the care and use of
laboratory animals (NIH Publication no. 85-23 Rev. 1985)
were observed throughout. The citrated whole blood was
centrifuged at 110g for 15 min at 228C. Platelet-rich plasma
(PRP) was collected from the supernatant. To re-establish
platelet activity, CaCl2 was added to the PRP to raise
[Ca2þ] by 2 mM. Before PRP incubation, the polymer-
coated microtiter plate wells were prehydrated by incubat-
ing with 200 mL PBS for 3 h at 378C to achieve the optimal
NO fluxes. The PBS solution was removed after this prein-
cubation period. Then, 100 mL of recalcified PRP was
added to each polymer-coated well and incubated for 1 h
at 378C under static conditions. The PRP was then dec-
anted and the wells were washed once with 200 mL PBS.
The entire duration from blood collection to the conclusion
of the platelet adhesion step was less than 3 h.
LDH assay
Adhered platelets were lysed using a lysing buffer
which was PBS plus 1% (w/v) Triton X-100 (Sigma) and
0.75% (w/v) bovine serum albumin (Sigma). One hundred
and fifty microliters of lysing buffer was incubated in each
well for 1 h at 378C with occasional agitation to completely
disrupt the platelet membranes. Then, 100 mL of each
lysate solution was pipetted into wells of a second 96-well
polystyrene microtiter plate (Fisher) that contained 100 mL
of reagent from an LDH assay kit (Roche Applied Sciences,
Indianapolis, IN). Absorbance of each well at 490 nm was
monitored for 1 h by a Labsystems Multiskan RC micro-
plate reader (Fisher). The slopes derived from the initial
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linear portion of the absorbance vs. time curves were used
for LDH quantification.
Blank experiments were performed in a similar manner.
Briefly, free LDH from rabbit muscle (Roche Molecular
Biochemicals, Mannheim, Germany) was dissolved in the
same lysing buffer at 3 mU/mL. Then, 150 mL of this free
LDH solution was placed in polymer-coated wells that
had been previously hydrated with PBS buffer for 3 h to
establish relatively stable NO release fluxes. The wells
were further incubated with the LDH solution for 1 h at
378C. In this way, the free LDH would have the same du-
ration of exposure to the same NO flux as the LDH origi-
nating from adhered platelets. The activity of the free LDH
was assayed in an identical manner as the LDH in the
lysate solutions.
Platelet counting and LDH calibration
Platelet rich plasma, obtained as described above, was
further centrifuged at 1500g for 15 min to produce platelet-
poor plasma (PPP) and a platelet pellet. The supernatant
PPP was carefully removed and the pellet of platelets was
gently resuspended in Tyrode’s buffer (137 mM NaCl,
95 mM NaHCO3, 1.8 mM CaCl2, 1.0 mM MgCl2, 2.7 mM
KCl, 0.4 mM NaH2PO4, and 5 mM D-glucose). The platelet
number in this suspension was counted by a Z1 Coulter
particle counter (Beckman-Coulter, Miami, FL). Varying
volumes of the platelet suspension derived from the pellet
were also placed in the lysing buffer and incubated at
378C for 1 h to completely release the LDH content of the
platelets. Then, 100 mL of each sample was mixed with
equal volume of the LDH assay kit reagent in polystyrene
microplate wells and assayed for LDH activity. The slopes
obtained were used to construct the calibration curve of
LDH activity versus platelet number, based on the Coulter
counter measurement of the original stock platelet suspen-
sion in cells per milliliters.
SEM analysis
Scanning electron microscopy (SEM) images for surfaces
of the various polymeric films were obtained in addition
to the LDH assays. After PRP incubation, adhered platelets
in some wells were fixed with 4% glutaraldehyde (Sigma)
for 1 h and then dehydrated in a series of ethanol solu-
tions and dried overnight.13 The bottom hemisphere was
cut, sputter-coated with gold, and examined by a Hitachi
S-3200N scanning electron microscope.
RESULTS AND DISCUSSION
NO-releasing polymer coatings
By using a microtiter plate with round-bottom
well, a polymer coating of relatively consistent thick-
ness can be achieved. The coating method described
in the Experimental Section yields a 1.74 cm2 poly-
mer film with about 60 mm thickness as determined
by an optical microscope. Addition of KTpClPB to
the underlying layer of the plasticized PVC film
helps to achieve a more stable NO flux by maintain-
ing charge neutrality and a constant pH within the
polymer phase as the DBHD/N2O2 species releases
NO and creates excess amine sites in the form of
DBHD.10 The NO release from DBHD/N2O2 decom-
position can occur via two mechanisms, proton-
driven34 or thermal dissociation.10 In this experi-
ment, temperature was maintained at 378C, except
for the final assay of LDH on the microplate reader.
Further, the pH of all solutions, including the antico-
agulated PRP, was kept at pH 7.4 for the precise
manipulation of NO fluxes.
All of the DBHD/N2O2 doped polymer films
exhibited continuous NO release for over 24 h. How-
ever, maximum NO fluxes were typically observed
between 2 and 5 h after wetting and the overall
magnitude of NO fluxes for the films was propor-
tional to the amount of DBHD/N2O2 doped within
the underlying polymer layer of the films. The typi-
cal NO release profiles for the coatings over the first
8 h are shown in Figure 1(A) for films doped with
0–4 wt % DBHD/N2O2 (and equal moles of
KTpClPB). It is obvious that the NO flux decays sig-
nificantly for the film with the highest NO donor
loading (4 wt %), while the others remain relatively
stable. Thus, to ensure that all platelet adhesion
studies are conducted during a period of relatively
constant NO flux, the time window between 3 and
4 h was selected for the platelet studies for all poly-
mer film compositions examined. Figure 1(B) shows
the statistics for the average flux levels at each
DBHD/N2O2 concentration (N ¼ 4 films). Average
fluxes during this period for the four different load-
ings were 0.93 (60.07), 1.69 (60.19), 3.59 (60.17), and
7.05 (60.25)  1010 mol cm2 min1, respectively.
Higher DBHD/N2O2 loadings (e.g., 8 wt %) were
also tested. They yielded fluxes of over 10  1010
mol cm2 min1. However, the polymer surfaces
become much rougher in this case, as determined by
SEM. This is likely due to the poor solubility of
DBHD/N2O2 in the polymer matrix and therefore the
surface roughness becomes more pronounced as the
DBHD/N2O2 concentration goes above 4 wt %.
Platelet adhesion
Unlike radioactive labeling of platelet, the major
advantage of the LDH assay is its simplicity which
minimizes possible activation of resting platelets.
Hence it has the potential to be more reproducible.
This attribute is critical for the evaluation of poten-
tially more biocompatible materials. Platelet adhe-
sion experiments were repeated using three different
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lots of blood (from different animals) and the results
were found to be quite reproducible. During the initial
incubation step, PRP was in contact with 0.834 cm2 of
polymer surface in each well. This surface area was
thus used to calculate the average platelet density on
the films after determining LDH activity. However, it
should be noted that the platelet coverage was not
even over the entire surface of the polymer films (as
determined by SEM), likely owing to the hemispheri-
cal shape of the wells. No fixation was used after
platelet adhesion since platelets fixed with the com-
mon fixative, glutaraldehyde, exhibited no LDH activ-
ity in the subsequent assay. Therefore, the unfixed
platelets were loosely adhered to the polymer surfa-
ces. Rinsing the wells three times yielded near-base-
line LDH activities across all polymers tested, prob-
ably because of the removal of adhered platelets. In
the final protocol, the wells were washed only once
after platelet incubation, which was found to be suffi-
cient to distinguish the extent of platelet adhesion as a
function of NO flux.
LDH assay
Prior to testing the effect of NO with respect to
platelet adhesion, it was necessary to establish that
NO has no effect on LDH activity. As a free radical,
NO is known to react with various enzymes, which
could possibly change their function and efficacy in
catalysis.35,36 Previous studies using the LDH assay
to assess the biocompatibility of polymers involved
evaluating only physically30,32 or chemically29,31
modified surfaces, not a material that releases a reac-
tive species such as NO. Consequently, it was crucial
to verify that any ‘‘observed’’ reduction in LDH ac-
tivity derived from experiments using PRP was
indeed the results of less adhered platelets rather
than any inhibition of LDH function in the presence
of continuous NO production.
An appropriate blank experiment was performed to
evaluate the influence of continuous NO release on
LDH activity. The enzyme concentration was set at
3 mU/mL since this was the level typically seen for
the control experiments (after cell lysis) with platelets.
Table I lists the free LDH activity in the control
and DBHD/N2O2 loaded wells, as well as the blank
with only plain 1:1 PVC/DOS films and no other
additives. Interestingly, the control wells have
slightly lower apparent LDH activities. LDH activity
also decreases with higher NO donor loading in the
polymer films. Since LDH has an isoelectric pH
value (pI) of 4.6, it will be negatively charged in the
PBS buffer. Thus, electrostatic interaction with the
positively-charged surface of the polymers is a possi-
ble explanation for the data shown in Table I. The
control polymer has the highest concentration (4 wt %)
TABLE I
Free LDH Activity After 1-h Incubation in Blank
(Plain PVC/DOS), Control, and Various NO-Releasing
Polymer-Coated Wells, as Determined by
Colorimetric Reaction Rate
Composition Blank Control 0.5% 1% 2% 4%
% LDH 100.0 89.7 103.6 98.1 98.9 93.3
SD 0.2 3.3 2.4 2.7 2.0 0.9
LDH activity was set to 100% in blank polymer wells
and others were plotted as the relative percentage.
N ¼ 3 for each polymer composition.
Figure 1. A: NO surface flux profiles for polymer-coated wells doped with 0.50, 1.0, 2.0, and 4.0 wt % DBHD/N2O2 and
equimolar KTpClPB. Wells were bathed in PBS at 378C as measured by chemiluminescence NO analyzer. B: Average NO
fluxes and SD during the 3–4 h time window for each DBHD/N2O2 loading. N ¼ 4 for each loading.
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of free amine (DBHD) which will gradually become
protonated to create a positively charged surface (as
it diffuses into the top coat layer of plain PVC poly-
mer). Once LDH is attracted to polymer surface, less
free LDH will be measured in the bulk solution,
hence giving a false-negative result. In the case of
the NO-releasing polymers, the amine will also be
formed upon hydrolysis of the diazeniumdiolate.34
However, at the time of assay, the diazeniumdiolate
is not 100% hydrolyzed and therefore amine sites in
NO-releasing polymers will be fewer compared to
those in the control. Because of this difference in
amine site density between the diazeniumdiolated
and nondiazeniumdiolated DBHD, the false nega-
tives cannot be simply corrected by simultaneously
collecting the LDH activities from same weight per-
cent control and DBHD/N2O2 loaded polymer films.
Even though a top coat was applied and bovine se-
rum albumin was added to the lysing buffer to mini-
mize nonspecific adsorption of LDH to the surface
of the polymers, it cannot be completely eliminated.
This false-negative result from the control polymers
suggested that the actual LDH levels in control poly-
mer coated wells could be 10% higher than that
measured from this LDH assay (see below).
Basal levels of LDH present in plasma could also
adsorb onto the polymers and contribute to a com-
mon baseline across all polymers tested. It has been
reported that PRP contains significant LDH activity
and that LDH activity can be detected on polymer
surfaces incubated with PPP.28 This adsorbed LDH
may later be desorbed during the cell lysing stage
and contribute to total LDH activity in this assay. To
prove this, PRP was replaced by PPP in the platelet
adhesion step, followed by identical washing, lysis,
and assay procedures. The baseline LDH level in
PPP was found to be equivalent to a platelet density
of about 1.00 (60.25)  105 cm2 on all polymers.
This baseline was not subtracted from the platelet
adhesion results, since there could be more cytolysis
in a given preparation of PPP (as it was prepared by
centrifugation at a much higher RCF than PRP) that
can give rise to a higher serum LDH level. However,
the presence of this background LDH activity
derived from the plasma suggests an even greater
reduction, percentage-wise, of adhered platelets on
NO-releasing polymers for the experiments de-
scribed below.
As shown in Figure 2, fewer platelets adhered on
polymer surfaces as the NO flux increases. The con-
trol polymer has an apparent platelet density of 14.0
(62.5)  105 cm2, while the 0.5, 1, 2, and 4%
DBHD/N2O2 doped films reduced the platelet den-
sity to 7.06 (61.0), 4.82 (60.79), 4.16 (60.68), and
2.96 (60.21)  105 cm2, respectively (N ¼ 12 for all
experiments, using at least three different blood lots
as the source for the PRP). In all cases, platelet adhe-
sion on the NO-releasing polymers is statistically dif-
ferent from the control (p < 0.0001). The influence of
LDH adsorption via the mechanisms discussed
above is insignificant as compared to the greater
reduction of LDH activities on NO-releasing poly-
mer surfaces. Further, the NO dose dependence on
platelet adhesion appears to be nonlinear (see
Fig. 2), with the largest percent change in platelet
adhesion occurring for the 0.5 wt % of DBHD/N2O2
doped film which provides the lowest NO flux. This
observation is consistent with the nonlinear dose
responses seen in previous studies that examined
platelet adhesion in the presence of varying levels of
NO or NO donors.6–9
Polymers with higher DBHD/N2O2 loadings (i.e.
8, 12, and 16 wt %) have also been tested in the
above manner. Given that DBHD/N2O2 has poor
solubility in these polymer matrices, it is not surpris-
ing that more platelet adhesion occurs on these
rougher surfaces despite the fact that the NO fluxes
are even higher. Indeed, another in vivo model with
DBHD/N2O2 coated on the inner walls of rabbit
extracorporeal circuits provided similar results—
with an intermediate level of DBHD/N2O2 loading
yielding the best biocompatibility (unpublished re-
sults). However, such results do not necessarily sug-
gest the inability of NO to inhibit platelet adhesion
and activation at those higher fluxes. Should a new
lipophilic NO donor be developed that can provide
smooth surfaces while still maintaining the desirable
properties of DBHD/N2O2 (e.g., minimal donor
leaching and wide range of attainable NO fluxes),
the effect of platelet inhibition by NO fluxes higher
than those tested herein could be explored in more
detail.
Figure 2. Platelet adhesion density on control and vari-
ous DBHD/N2O2 loaded polymer coatings as determined
by LDH assay. N ¼ 12 for each polymer composition.
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SEM analysis
To support LDH assay, SEM images were taken
from the control and 4% DBHD/N2O2 doped films.
The SEM micrographs shown in Figure 3 were taken
at the center of the well bottoms. It is obvious that
platelets on NO-releasing surfaces were much less
activated compared with those on the control surface.
Also, there were much fewer platelets per viewing
area on NO-releasing surfaces. However, SEM does
not serve as a quantitative measure since the surface
it examined constitutes only a tiny portion of the total
surface in contact with PRP. This is the reason why
LDH assay was used to evaluate average platelet ad-
hesion over the entire surfaces.
CONCLUSION
The thromboresistance of healthy endothelium is a
complex, synergistic mechanism in which NO plays
a very important role. In this article, an in vitro plate-
let adhesion assay via platelet LDH release is
described to study the hemocompatibility of polymer
films that continuously release small fluxes of NO,
chemically, to mimic the function of human endothe-
lium. Using this LDH assay, it was found that con-
tinuous NO release from 1:1 PVC/DOS polymer film
matrices at close to physiological fluxes (0.93  1010
to 7.05  1010 mol cm2 min1) helps to reduce
platelet adhesion from 14.0 (62.1)  105 to 2.96
(60.18)  105 cells cm2 on such polymer surfaces.
SEM micrographs support the findings with the
LDH assay by showing that the platelets were fewer
in number and less activated on the NO-releasing
surfaces. Accuracy of this assay is somewhat affected
by the adsorption of LDH on polymer surfaces.
Because of electrostatic interactions between the pos-
itively-charged polymer surface and the negatively-
charged LDH, the actual adhered platelets on poly-
mers with the highest NO flux could be 7% more
Figure 3. SEM micrographs of adhered platelets on control polymers (a and b) and 4 wt % DBHD/N2O2 loaded poly-
mers (c and d) after 1 h PRP incubation.
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than that measured in this assay. However, this
false-negative is more significant (10%) with con-
trol polymers which have the highest positive
charge. The basal LDH level present in plasma is
likely to contribute to a common baseline for all poly-
mers tested, a value that is difficult to precisely
determine. Nevertheless, taking such background
levels into consideration only strengthens our find-
ing that the LDH assay scheme can be employed to
study, in vitro, the effect of NO release on platelet
adhesion.
It should be noted that the fluxes determined to
reduce platelet adhesion for the in vitro studies
described above may be different than the fluxes
required to obtain a similar decrease in platelet adhe-
sion when the same polymer surfaces are in contact
with flowing whole blood. This is because the surface
concentrations of NO gas will vary depending on the
composition of the flowing blood, including scaveng-
ing reactions with high levels of endogenous hemo-
globin in red blood cells, thiol groups, and normal ox-
idation of NO by blood oxygen levels. In addition,
platelet adhesion will also be influenced by hemody-
namics.37 Clearly, the methodology reported here
using microtiter plate wells coated with polymer that
release NO only provides a preliminary assessment
as to the potential capability of such coatings to pre-
vent thrombosis when used in vivo. Ultimately, the
LDH assay methodology described herein should also
be used to assess platelet adhesion on NO-releasing
materials that are tested intravascularly. Such studies
are currently in progress in this laboratory.
We thank Amy Skrzypchak and Nathan Lafayette in the
Extracorporeal Membrane Oxygenation (ECMO) lab at
University of Michigan medical school for preparing the
anticoagulated rabbit blood.
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